Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00424359
Status:
COMPLETED
Last Update Posted:
2011-05-16
First Post:
2007-01-17
Brief Title:
Ambulation Study in Multiple Sclerosis
Sponsor:
Brown Theodore R MD MPH
Organization:
Brown Theodore R MD MPH
Study Overview
Official Title:
A Prospective Study of Clinical Indices as Predictors of Ambulatory Effectiveness in Multiple Sclerosis
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a study comparing clinical tests of walking and balance The goal of this study is to discover which of those tests are best at predicting walking problems due to MS
Detailed Description:
This study includes
Three study visits to the MS Center at Evergreen wearing a pedometer for two one-week periods to record walking during regular daily activities keeping a diary for any walking problems such as falls and slips
Subjects must meet the following criteria
Diagnosis of MS any form 18-70 years of age be on stable MS treatment OR no MS treatment for the last three months no scheduled hospitalization in the next six months
Three study visits to the MS Center at Evergreen wearing a pedometer for two one-week periods to record walking during regular daily activities keeping a diary for any walking problems such as falls and slips
Subjects must meet the following criteria
Diagnosis of MS any form 18-70 years of age be on stable MS treatment OR no MS treatment for the last three months no scheduled hospitalization in the next six months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Independent Grants 235-14-22 | None | None | None |
| Pfizer Inc | None | None | None |